Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys.
Bajaj S, Chen S, Creswell R, Naidoo R, Tsui JL, Kolade O, Nicholson G, Lehmann B, Hay JA, Kraemer MUG, Aguas R, Donnelly CA, Fowler T, Hopkins S, Cantrell L, Dahal P, White LJ, Stepniewska K, Voysey M, Lambert B; EY-Oxford Health Analytics Consortium. Bajaj S, et al. Among authors: stepniewska k. Lancet Digit Health. 2024 Nov;6(11):e778-e790. doi: 10.1016/S2589-7500(24)00169-9. Lancet Digit Health. 2024. PMID: 39455191 Free article.
An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol.
Naidoo R, Lambert B, Voysey M, Shretta R, Keene CM, Wanat M, Andersen-Waine B, Dahal P, Stepniewska K, Hounsell R, Molyneux S, Pinto-Duschinsky S, Rowe E, Yenidogan G, Fowler T, White L, Consortium EHA. Naidoo R, et al. Among authors: stepniewska k. BMJ Open. 2024 Jun 16;14(6):e077271. doi: 10.1136/bmjopen-2023-077271. BMJ Open. 2024. PMID: 38885988 Free PMC article.
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review.
Chhajed R, Dahal P, Singh-Phulgenda S, Brack M, Naylor C, Sundar S, Alves F, Stepniewska K, Guerin PJ. Chhajed R, et al. Among authors: stepniewska k. Lancet Reg Health Southeast Asia. 2023 Dec 6;22:100317. doi: 10.1016/j.lansea.2023.100317. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2023. PMID: 38482151 Free PMC article.
Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis.
Kumar R, Dahal P, Singh-Phulgenda S, Siddiqui NA, Munir A, Naylor C, Wilson J, Buck G, Rahi M, Malaviya P, Alves F, Sundar S, Ritmeijer K, Stepniewska K, Guérin PJ, Pandey K. Kumar R, et al. Among authors: stepniewska k. BMJ Open. 2023 Oct 28;13(10):e074679. doi: 10.1136/bmjopen-2023-074679. BMJ Open. 2023. PMID: 37898487 Free PMC article.
Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis.
Munir A, Dahal P, Kumar R, Singh-Phulgenda S, Siddiqui NA, Naylor C, Wilson J, Buck G, Rahi M, Alves F, Malaviya P, Sundar S, Ritmeijer K, Stepniewska K, Pandey K, Guérin PJ, Musa A. Munir A, et al. Among authors: stepniewska k. BMJ Open. 2023 Dec 14;13(12):e074841. doi: 10.1136/bmjopen-2023-074841. BMJ Open. 2023. PMID: 38101841 Free PMC article.
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Singh-Phulgenda S, Kumar R, Dahal P, Munir A, Rashan S, Chhajed R, Naylor C, Maguire BJ, Siddiqui NA, Harriss E, Rahi M, Alves F, Sundar S, Stepniewska K, Musa A, Guerin PJ, Pandey K. Singh-Phulgenda S, et al. Among authors: stepniewska k. PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0011635. doi: 10.1371/journal.pntd.0011635. eCollection 2024 Apr. PLoS Negl Trop Dis. 2024. PMID: 38626228 Free PMC article.
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Commons RJ, Rajasekhar M, Allen EN, Yilma D, Chotsiri P, Abreha T, Adam I, Awab GR, Barber BE, Brasil LW, Chu CS, Cui L, Edler P, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Hamid MMA, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Longley RJ, Monteiro WM, Pasaribu AP, Poespoprodjo JR, Richmond CL, Rijal KR, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Zuluaga-Idarraga LM, Workman LJ, Tarning J, Stepniewska K, Guerin PJ, Simpson JA, Barnes KI, Price RN; WorldWide Antimalarial Resistance Network Paediatric Primaquine Vivax Study Group. Commons RJ, et al. Among authors: stepniewska k. Lancet Child Adolesc Health. 2024 Nov;8(11):798-808. doi: 10.1016/S2352-4642(24)00210-4. Epub 2024 Sep 24. Lancet Child Adolesc Health. 2024. PMID: 39332427 Free PMC article.
186 results